These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34531550)
1. Gene therapy: perspectives from young adults with Leber's congenital amaurosis. Napier MP; Selvan K; Hayeems RZ; Shuman C; Chitayat D; Sutherland JE; Day MA; Héon E Eye (Lond); 2022 Nov; 36(11):2088-2093. PubMed ID: 34531550 [TBL] [Abstract][Full Text] [Related]
2. Leber's Congenital Amaurosis and Gene Therapy. Takkar B; Bansal P; Venkatesh P Indian J Pediatr; 2018 Mar; 85(3):237-242. PubMed ID: 28685406 [TBL] [Abstract][Full Text] [Related]
3. Plasticity of the human visual system after retinal gene therapy in patients with Leber's congenital amaurosis. Ashtari M; Zhang H; Cook PA; Cyckowski LL; Shindler KS; Marshall KA; Aravand P; Vossough A; Gee JC; Maguire AM; Baker CI; Bennett J Sci Transl Med; 2015 Jul; 7(296):296ra110. PubMed ID: 26180100 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis. Rakoczy EP; Narfström K Int J Biochem Cell Biol; 2014 Nov; 56():153-7. PubMed ID: 25286304 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy for Leber congenital amaurosis: advances and future directions. Hufnagel RB; Ahmed ZM; Corrêa ZM; Sisk RA Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1117-28. PubMed ID: 22644094 [TBL] [Abstract][Full Text] [Related]
6. Available Evidence on Leber Congenital Amaurosis and Gene Therapy. Alkharashi M; Fulton AB Semin Ophthalmol; 2017; 32(1):14-21. PubMed ID: 27686653 [TBL] [Abstract][Full Text] [Related]
7. Update on Viral Gene Therapy Clinical Trials for Retinal Diseases. Cheng SY; Punzo C Hum Gene Ther; 2022 Sep; 33(17-18):865-878. PubMed ID: 36074935 [TBL] [Abstract][Full Text] [Related]
8. Leber's Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations. Huang CH; Yang CM; Yang CH; Hou YC; Chen TC Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440435 [TBL] [Abstract][Full Text] [Related]
9. [Gene therapy for vision restoration in patients with Leber congenital amaurosis (LCA) due to RPE65 gene mutations: beginning the phase IV trial]. Chacón-Camacho ÓF; Zenteno JC Gac Med Mex; 2017; 153(2):276-278. PubMed ID: 28474714 [TBL] [Abstract][Full Text] [Related]
10. Leber congenital amaurosis: Current genetic basis, scope for genetic testing and personalized medicine. Kondkar AA; Abu-Amero KK Exp Eye Res; 2019 Dec; 189():107834. PubMed ID: 31639339 [TBL] [Abstract][Full Text] [Related]
11. Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections. Malvasi M; Casillo L; Avogaro F; Abbouda A; Vingolo EM Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762059 [TBL] [Abstract][Full Text] [Related]
12. Improvement and decline in vision with gene therapy in childhood blindness. Jacobson SG; Cideciyan AV; Roman AJ; Sumaroka A; Schwartz SB; Heon E; Hauswirth WW N Engl J Med; 2015 May; 372(20):1920-6. PubMed ID: 25936984 [TBL] [Abstract][Full Text] [Related]
13. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Cideciyan AV; Jacobson SG; Beltran WA; Sumaroka A; Swider M; Iwabe S; Roman AJ; Olivares MB; Schwartz SB; Komáromy AM; Hauswirth WW; Aguirre GD Proc Natl Acad Sci U S A; 2013 Feb; 110(6):E517-25. PubMed ID: 23341635 [TBL] [Abstract][Full Text] [Related]
15. Long-term effect of gene therapy on Leber's congenital amaurosis. Bainbridge JW; Mehat MS; Sundaram V; Robbie SJ; Barker SE; Ripamonti C; Georgiadis A; Mowat FM; Beattie SG; Gardner PJ; Feathers KL; Luong VA; Yzer S; Balaggan K; Viswanathan A; de Ravel TJ; Casteels I; Holder GE; Tyler N; Fitzke FW; Weleber RG; Nardini M; Moore AT; Thompson DA; Petersen-Jones SM; Michaelides M; van den Born LI; Stockman A; Smith AJ; Rubin G; Ali RR N Engl J Med; 2015 May; 372(20):1887-97. PubMed ID: 25938638 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Simonelli F; Maguire AM; Testa F; Pierce EA; Mingozzi F; Bennicelli JL; Rossi S; Marshall K; Banfi S; Surace EM; Sun J; Redmond TM; Zhu X; Shindler KS; Ying GS; Ziviello C; Acerra C; Wright JF; McDonnell JW; High KA; Bennett J; Auricchio A Mol Ther; 2010 Mar; 18(3):643-50. PubMed ID: 19953081 [TBL] [Abstract][Full Text] [Related]
17. Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients. Melillo P; Pecchia L; Testa F; Rossi S; Bennett J; Simonelli F Biomed Eng Online; 2012 Jul; 11():40. PubMed ID: 22812667 [TBL] [Abstract][Full Text] [Related]
18. A novel nonviral gene delivery system for treating Leber's congenital amaurosis. Sun D; Schur RM; Lu ZR Ther Deliv; 2017 Oct; 8(10):823-826. PubMed ID: 28944740 [No Abstract] [Full Text] [Related]
19. Evaluation of Ocular Gene Therapy in an Italian Patient Affected by Congenital Leber Amaurosis Type 2 Treated in Both Eyes. Testa F; Maguire AM; Rossi S; Marshall K; Auricchio A; Melillo P; Bennett J; Simonelli F Adv Exp Med Biol; 2016; 854():533-9. PubMed ID: 26427456 [TBL] [Abstract][Full Text] [Related]
20. Leber congenital amaurosis, from darkness to light: An ode to Irene Maumenee. Coussa RG; Lopez Solache I; Koenekoop RK Ophthalmic Genet; 2017; 38(1):7-15. PubMed ID: 28095138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]